Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19.

A cheap, generically available anti-depressant may reduce the risk of severe Covid-19 disease by close to a third in people at high risk, researchers reported Wednesday.

Higher-Dose Fluvoxamine Fails for COVID Outpatients — Recovery time with 100-mg dose no different than placebo by Ian Ingram , Managing Editor, MedPage Today November 17, 2023 • 3 min read ...

A safe, well-established antidepressant pill has proven effective at heading off severe COVID-19 cases, recent studies indicate. Fluvoxamine dramatically reduced the risk of hospitalization for ...

Participants were randomized in a 1:1 ratio to receive either fluvoxamine (50 mg twice daily on day 1, followed by 100 mg twice daily for 12 days) or placebo, ...